Court Orders Scientific Misconduct Labels Removed From Fisher's Work

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

WASHINGTON--Bernard Fisher, MD, Distinguished Service Professor of Surgery, University of Pittsburgh, has won a court order requiring that scientific misconduct labels be removed from citations of his papers in federal databases (Cancerlit and Medline).

WASHINGTON--Bernard Fisher, MD, Distinguished Service Professorof Surgery, University of Pittsburgh, has won a court order requiringthat scientific misconduct labels be removed from citations ofhis papers in federal databases (Cancerlit and Medline).

The labels were added at the insistence of the Office of ResearchIntegrity after last year's revelations of misconduct by a Montrealparticipant in NSABP trials headed by Dr. Fisher. The government,through faxes sent to distributors of the databases, will alsoapologize for the labels, stating that Dr. Fisher's own researchhas never been found to be at fault.

Recent Videos
Thomas Powles, MBBS, MRCP, MD, highlighted fatigue, nausea, and peripheral neuropathy as toxicities observed with enfortumab vedotin plus pembrolizumab.
According to Megan Mullins, PhD, MPH, challenging cultural norms surrounding death and dying may reduce the receipt of low-value end-of-life cancer care.
Earlier and more frequent talks about disabling ICDs with patients receiving end-of-life care and their families may help avoid excessive pain.
3 experts in this video
3 experts in this video
Large international meetings may facilitate conversations regarding disparities of care outside of high-income countries.
6 experts are featured in this series.
6 experts are featured in this series.
Related Content